vs
费森尤斯医疗（FMS）与标普全球（VG）财务数据对比。点击上方公司名可切换其他公司
费森尤斯医疗的季度营收约是标普全球的1.2倍（$5.5B vs $4.4B），标普全球净利率更高（26.8% vs 7.9%，领先18.9%），标普全球同比增速更快（191.7% vs -0.3%）
费森尤斯医疗是德国知名医疗保健企业，核心业务为肾脏透析服务，在全球运营4171家门诊透析中心，服务约34.54万名患者。公司主要为终末期肾病患者提供治疗服务，该类患者需终身每周接受3次透析治疗以维持生命。
标普全球是总部位于美国纽约曼哈顿的上市企业，核心业务涵盖金融信息与数据分析、能源及大宗商品情报服务，旗下拥有标普全球评级、标普全球能源、标普全球市场财智、印度信用评级机构CRISIL等子品牌，同时是标普道琼斯指数合资公司的控股股东。
FMS vs VG — 直观对比
营收规模更大
FMS
是对方的1.2倍
$4.4B
营收增速更快
VG
高出192.0%
-0.3%
净利率更高
VG
高出18.9%
7.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $5.5B | $4.4B |
| 净利润 | $434.2M | $1.2B |
| 毛利率 | 27.4% | — |
| 营业利润率 | 11.7% | 38.7% |
| 净利率 | 7.9% | 26.8% |
| 营收同比 | -0.3% | 191.7% |
| 净利润同比 | 240.4% | 20.3% |
| 每股收益（稀释后） | — | $0.41 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FMSVG
| Q4 25 | $5.5B | $4.4B | ||
| Q3 25 | — | $3.3B | ||
| Q2 25 | — | $3.1B | ||
| Q1 25 | — | $2.9B | ||
| Q4 24 | $5.5B | $1.5B | ||
| Q3 24 | — | $926.0M | ||
| Q2 24 | — | $1.1B | ||
| Q1 24 | — | $1.4B |
净利润FMSVG
| Q4 25 | $434.2M | $1.2B | ||
| Q3 25 | — | $550.0M | ||
| Q2 25 | — | $475.0M | ||
| Q1 25 | — | $517.0M | ||
| Q4 24 | $127.6M | $990.0M | ||
| Q3 24 | — | $-294.0M | ||
| Q2 24 | — | $352.0M | ||
| Q1 24 | — | $698.0M |
毛利率FMSVG
| Q4 25 | 27.4% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 25.0% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
营业利润率FMSVG
| Q4 25 | 11.7% | 38.7% | ||
| Q3 25 | — | 39.7% | ||
| Q2 25 | — | 33.5% | ||
| Q1 25 | — | 37.3% | ||
| Q4 24 | 5.1% | 39.0% | ||
| Q3 24 | — | 20.4% | ||
| Q2 24 | — | 32.8% | ||
| Q1 24 | — | 43.6% |
净利率FMSVG
| Q4 25 | 7.9% | 26.8% | ||
| Q3 25 | — | 16.5% | ||
| Q2 25 | — | 15.3% | ||
| Q1 25 | — | 17.9% | ||
| Q4 24 | 2.3% | 65.0% | ||
| Q3 24 | — | -31.7% | ||
| Q2 24 | — | 31.8% | ||
| Q1 24 | — | 49.4% |
每股收益（稀释后）FMSVG
| Q4 25 | — | $0.41 | ||
| Q3 25 | — | $0.16 | ||
| Q2 25 | — | $0.14 | ||
| Q1 25 | — | $0.15 | ||
| Q4 24 | — | $0.35 | ||
| Q3 24 | — | $-0.15 | ||
| Q2 24 | — | $0.12 | ||
| Q1 24 | — | $0.25 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.7B | $2.4B |
| 总债务越低越好 | — | $34.2B |
| 股东权益账面价值 | $15.4B | $6.7B |
| 总资产 | $33.5B | $53.4B |
| 负债/权益比越低杠杆越低 | — | 5.07× |
8季度趋势，按日历期对齐
现金及短期投资FMSVG
| Q4 25 | $1.7B | $2.4B | ||
| Q3 25 | — | $1.9B | ||
| Q2 25 | — | $2.2B | ||
| Q1 25 | — | $3.6B | ||
| Q4 24 | $1.3B | $3.6B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
总债务FMSVG
| Q4 25 | — | $34.2B | ||
| Q3 25 | — | $32.6B | ||
| Q2 25 | — | $30.0B | ||
| Q1 25 | — | $29.3B | ||
| Q4 24 | — | $29.3B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益FMSVG
| Q4 25 | $15.4B | $6.7B | ||
| Q3 25 | — | $5.7B | ||
| Q2 25 | — | $5.3B | ||
| Q1 25 | — | $4.9B | ||
| Q4 24 | $17.0B | $2.9B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
总资产FMSVG
| Q4 25 | $33.5B | $53.4B | ||
| Q3 25 | — | $50.1B | ||
| Q2 25 | — | $46.5B | ||
| Q1 25 | — | $45.1B | ||
| Q4 24 | $36.3B | $43.5B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
负债/权益比FMSVG
| Q4 25 | — | 5.07× | ||
| Q3 25 | — | 5.73× | ||
| Q2 25 | — | 5.69× | ||
| Q1 25 | — | 6.01× | ||
| Q4 24 | — | 10.11× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $2.9B | $2.1B |
| 自由现金流经营现金流 - 资本支出 | — | $-1.5B |
| 自由现金流率自由现金流/营收 | — | -34.1% |
| 资本支出强度资本支出/营收 | — | 81.6% |
| 现金转化率经营现金流/净利润 | 6.67× | 1.77× |
| 过去12个月自由现金流最近4个季度 | — | $-6.8B |
8季度趋势，按日历期对齐
经营现金流FMSVG
| Q4 25 | $2.9B | $2.1B | ||
| Q3 25 | — | $1.9B | ||
| Q2 25 | — | $1.5B | ||
| Q1 25 | — | $1.1B | ||
| Q4 24 | $2.6B | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $638.0M |
自由现金流FMSVG
| Q4 25 | — | $-1.5B | ||
| Q3 25 | — | $-1.4B | ||
| Q2 25 | — | $-1.5B | ||
| Q1 25 | — | $-2.4B | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $-2.4B |
自由现金流率FMSVG
| Q4 25 | — | -34.1% | ||
| Q3 25 | — | -42.4% | ||
| Q2 25 | — | -49.1% | ||
| Q1 25 | — | -81.3% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -167.3% |
资本支出强度FMSVG
| Q4 25 | — | 81.6% | ||
| Q3 25 | — | 98.9% | ||
| Q2 25 | — | 96.1% | ||
| Q1 25 | — | 119.8% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 212.4% |
现金转化率FMSVG
| Q4 25 | 6.67× | 1.77× | ||
| Q3 25 | — | 3.42× | ||
| Q2 25 | — | 3.07× | ||
| Q1 25 | — | 2.15× | ||
| Q4 24 | 20.20× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 0.91× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FMS
暂无分部数据
VG
| Plaquemines Project Segment | $3.4B | 76% |
| Calcasieu Project Segment | $841.0M | 19% |
| Other | $208.0M | 5% |
